Si-Bone (SIBN) Cash from Investing Activities (2017 - 2026)
Si-Bone (SIBN) posted quarterly Cash from Investing Activities of -$6.2 million for Q1 2026, down 158.63% year-over-year from $10.6 million in Q1 2025, and down 147.84% quarter-over-quarter from $13.0 million in Q4 2025.
Si-Bone (SIBN) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Si-Bone's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$6.2 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 158.63% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at -$12.7 million (down 175.13% YoY), while the FY2025 annual figure was $4.2 million, down 67.04% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$6.2 million, down from $13.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $13.0 million in Q4 2025, with the low at -$54.9 million in Q3 2023.
- The 5-year median for Cash from Investing Activities is $2.3 million (2023), against an average of -$3.1 million.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities slumped 21349.44% in 2023, then surged 200.35% in 2025.
- Si-Bone's Cash from Investing Activities stood at $89000.0 in 2022, then plunged by 21349.44% to -$18.9 million in 2023, then surged by 122.93% to $4.3 million in 2024, then soared by 200.35% to $13.0 million in 2025, then plunged by 147.84% to -$6.2 million in 2026.
- Business Quant data shows SIBN's Cash from Investing Activities at -$6.2 million in Q1 2026, $13.0 million in Q4 2025, and -$10.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Si-Bone | 887.32 Mn | 741.38 Mn | 44.55 Mn | -2.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.74 Mn |
| Jun 30, 2026 | -2.74 Mn |
| Mar 31, 2026 | -6.23 Mn |
| Mar 31, 2026 | -6.23 Mn |
| Dec 31, 2025 | 13.03 Mn |
| Dec 31, 2025 | 13.03 Mn |
| Sep 30, 2025 | -10.03 Mn |
| Sep 30, 2025 | -10.03 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Mar 31, 2025 | 10.63 Mn |
| Dec 31, 2024 | 4.34 Mn |
| Dec 31, 2024 | 4.34 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | -1.83 Mn |
| Jun 30, 2024 | -1.83 Mn |
| Mar 31, 2024 | 6.35 Mn |
| Mar 31, 2024 | 6.35 Mn |